Background Hepatitis C virus (HCV) treatment drugs--such as Harvoni, Sovaldi, Viekira Pak, and Technivie--are classified as Direct Acting Antiviral Agents (DAAs). The relationship between DAA treatment and liver cancer, or hepatocellular carcinoma (HCC), is a complex one that has been the subject of several studies in the past year. While … [Read more...]
July 2017 Update: Any Link Between Hepatitis C Drugs and Liver Cancer?
A recent study from the July 2017 edition of Gastroenterology sought to investigate the relationship between Direct Acting Antiviral Agents (DAA) -- such as Harvoni, Sovaldi, Viekira Pak, and Technivie -- and liver cancer, or hepatocellular carcinoma (HCC). Previously, the medical literature on this subject was relatively sparse, as well as … [Read more...]